(Total Views: 609)
Posted On: 11/28/2021 1:19:29 PM
Post# of 148899
It is mildly amusing to read generalizations about investors, like 'only a clueless little darling', 'only a fool', or 'only a DongDongU alum' would do XXX (sell, take a buyout, other).
I don't need you to chime in and defend anything, but you already know that Real Life can rear up and smack you hard, leaving you or your family with a hand print on your ass cheeks, at the least (sorry for the butt stuff, Respert)
There are so many possible Real Life reasons for shareholders to take off some of their risk. That is such an obvious sentence that it really does make the 'only a ...' judgments seem comical.
Didn't know the person, but this week's detailed Covid story is an easy example. She got Covid, mild at first, then started circling the drain, cardiac ejection fraction was 10% (Mayo Clinic says normal about 50-75%, Cleveland Clinic says 55-70%). No room at the ultra critical care spots, and she died. She was 36 with 3 kids.
The triple negative breast cancer stories are similarly horrid but they just move at a slower speed, with more time for first- and secondhand agony.
Leronlimab is gonna change that. I'm not going to worry about what other people are doing with their portfolios, etc. Cheers.
I don't need you to chime in and defend anything, but you already know that Real Life can rear up and smack you hard, leaving you or your family with a hand print on your ass cheeks, at the least (sorry for the butt stuff, Respert)
There are so many possible Real Life reasons for shareholders to take off some of their risk. That is such an obvious sentence that it really does make the 'only a ...' judgments seem comical.
Didn't know the person, but this week's detailed Covid story is an easy example. She got Covid, mild at first, then started circling the drain, cardiac ejection fraction was 10% (Mayo Clinic says normal about 50-75%, Cleveland Clinic says 55-70%). No room at the ultra critical care spots, and she died. She was 36 with 3 kids.
The triple negative breast cancer stories are similarly horrid but they just move at a slower speed, with more time for first- and secondhand agony.
Leronlimab is gonna change that. I'm not going to worry about what other people are doing with their portfolios, etc. Cheers.
(8)
(0)
Scroll down for more posts ▼